Decreased In Situ Insulin Receptor Dephosphorylation in Hyperglycemia-Induced Insulin Resistance in Rat Adipocytes
- From the Department of Medicine (I.G.F.), Mount Sinai Hospital and the University Health Network; the Department of Physiology (P.S., I.G.F.) and Banting and Best Diabetes Centre (S.T., H.L.-T., P.S., R.L., I.G.F.), University of Toronto, Toronto, Ontario, Canada; and the Department of Medicine and the Dorrance H. Hamilton Research Laboratories (B.J.G.), Jefferson Medical College, Philadelphia, Pennsylvania.
- Address correspondence and reprint requests to Dr. I.G. Fantus, Department of Medicine, Mount Sinai Hospital, 600 University Ave., Rm. 780, Toronto, ON M5G 1X5, Canada. E-mail: fantus{at}mshri.on.ca .
Abstract
The regulation of insulin receptor (IR) tyrosine (tyr) phosphorylation is a key step in the control of insulin signaling. Augmented IR tyr dephosphorylation by protein tyrosine phosphatases (PTPs) may contribute to insulin resistance. To investigate this possibility in hyperglycemia-induced insulin resistance, primary cultured rat adipocytes were rendered insulin-resistant by chronic exposure (18 h) to 15 mmol/l glucose combined with 10-7 mol/l insulin. Insulin-resistant adipocytes showed a decrease in insulin sensitivity and a maximum response of 2-deoxyglucose uptake, which was associated with a decrease in maximum insulin-stimulated IR tyr phosphorylation in situ. To assess tyr dephosphorylation, IRs of insulin-stimulated permeabilized adipocytes were labeled with [γ-32P]ATP and chased for 2 min with unlabeled ATP in the presence of EDTA. In a nonradioactive protocol, insulin-stimulated adipocytes were permeabilized and exposed to EDTA and erbstatin for 2 min, and IRs were immunoblotted with anti-phosphotyrosine (pY) antibodies. Both methods showed a similar diminished extent of IR tyr dephosphorylation in resistant cells. Immunoblotting of four candidate IR-PTPs demonstrated no change in PTP1B or the SH2 domain containing phosphatase-2 (SHP-2), whereas a significant decrease in leukocyte antigen-related phosphatase (LAR) (51 ± 3% of control) and an increase in PTP-α (165 ± 16%) were found. Activity of immunoprecipitated PTPs toward a triple tyr phosphorylated IR peptide revealed a correlation with protein content for PTP1B, SHP-2, and LAR but a decrease in apparent specific activity of PTP-α. The data indicate that decreased IR tyr phosphorylation in hyperglycemia-induced insulin resistance is not due to enhanced dephosphorylation. The diminished IR tyr dephosphorylation observed in this model is associated with decreased LAR protein content and activity.
Footnotes
-
2-DG, 2-deoxyglucose; BSA, bovine serum albumin; DMEM, Dulbecco's modified Eagle's medium; DTT, dithiothreitol; ECL, enhanced chemiluminescence; FBS, fetal bovine serum; GST, glutathione S-transferase; high G/I, high glucose and high insulin; IR, insulin receptor; IRS, insulin receptor substrate; LAR, leukocyte antigen-related phosphatase; PKC, protein kinase C; PMSF, phenylmethylsulfonylfluoride; PTP, protein tyrosine phosphatase; pY, phosphotyrosine; SHP-2, SH2 domain containing phosphatase-2; TIU, trypsin inhibitor unit; tyr, tyrosine; WGA, wheat germ agglutinin.
-
- Accepted September 8, 2000.
- Received August 10, 1999.
- by the American Diabetes Association, Inc.














